144 related articles for article (PubMed ID: 24624759)
1. [Mistletoe therapy is not consistent with good clinical practice].
Eckerdal G
Lakartidningen; 2014 Jan 29-Feb 4; 111(5):128-9. PubMed ID: 24624759
[No Abstract] [Full Text] [Related]
2. [Mistletoe therapy in cancer treatment: pros and cons].
Wiebelitz KR; Beer AM; Heinrich B
MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
[No Abstract] [Full Text] [Related]
3. [Value of mistletoe therapy in carcinoma patients].
Rostock M; Unger C
Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
[No Abstract] [Full Text] [Related]
4. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
5. The case for mistletoe in the treatment of laryngeal cancer.
Shakeel M; Trinidade A; Geider S; Ah-See KW
J Laryngol Otol; 2014 Mar; 128(3):302-6. PubMed ID: 24548675
[TBL] [Abstract][Full Text] [Related]
6. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
Pierach CA
Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
[No Abstract] [Full Text] [Related]
7. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
8. [Possibilities and limits of mistletoe therapy in cancer patients].
Hoffmann J
Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
[No Abstract] [Full Text] [Related]
9. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
[TBL] [Abstract][Full Text] [Related]
10. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
Arm F
Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
[No Abstract] [Full Text] [Related]
11. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
Mengs U; Göthel D; Leng-Peschlow E
Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
[TBL] [Abstract][Full Text] [Related]
12. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
Mengs U; Witthohn K; Schwarz T; Lentzen H
Wien Med Wochenschr; 1999; 149(8-10):262-4. PubMed ID: 10483695
[TBL] [Abstract][Full Text] [Related]
13. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
[No Abstract] [Full Text] [Related]
14. Mistletoe in conventional oncological practice: exemplary cases.
Legnani W
Integr Cancer Ther; 2008 Sep; 7(3):162-71. PubMed ID: 18956494
[TBL] [Abstract][Full Text] [Related]
15. [Metaphorical aspects of mistletoe therapy in patients' experiences--a qualitative study].
Konitzer M; Doering T; Fischer GC
Forsch Komplementarmed Klass Naturheilkd; 2001 Apr; 8(2):68-79. PubMed ID: 11340313
[TBL] [Abstract][Full Text] [Related]
16. Mistletoe in immunology and the clinic (short review).
Stein GM; Schietzel M; Büssing A
Anticancer Res; 1998; 18(5A):3247-9. PubMed ID: 9858890
[TBL] [Abstract][Full Text] [Related]
17. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
[No Abstract] [Full Text] [Related]
18. Apparent response of small cell lung cancer to an extract of mistletoe and homoeopathic treatment.
Bradley GW; Clover A
Thorax; 1989 Dec; 44(12):1047-8. PubMed ID: 2559483
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
20. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
